Suchergebnisse - "Gelber, R D"

PubPharm (40)

1

Continuous versus intermittent extended adjuvant letrozole for breast cancer : final results of randomized phase III SOLE (Study of Letrozole Extension) and SOLE Estrogen Substudy

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2021

von Jerusalem, G. | Farah, S. | Courtois, A. | +30

2

Tailoring therapies--improving the management of early breast cancer : St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2015

von Coates, A. | Winer, E. | Goldhirsch, A. | +54

CommentIn: Ann Oncol. 2015 Aug;26(8):1519-20. - PMID 26063634

3

Chemotherapy benefit for 'ER-positive' breast cancer and contamination of nonluminal subtypes—waiting for TAILORx and RxPONDER

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2015

von Sun, Z. | Prat, A. | Cheang, M. | +2

4

Patterns and risk factors for locoregional failures after mastectomy for breast cancer : an International Breast Cancer Study Group report

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2012

von Karlsson, P. | Cole, B. | Chua, B. | +12

5

Prognosis of medullary breast cancer : analysis of 13 International Breast Cancer Study Group (IBCSG) trials

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2012

von Huober, J. | Gelber, S. | Goldhirsch, A. | +7

6

Long-term results of International Breast Cancer Study Group Trial VIII : adjuvant chemotherapy plus goserelin compared with either therapy alone for premenopausal patients with node-negative breast cancer

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2011

von Karlsson, P. | Sun, Z. | Braun, D. | +14

7

Which patients benefit most from adjuvant aromatase inhibitors? Results using a composite measure of prognostic risk in the BIG 1-98 randomized trial

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2011

von Viale, G. | Regan, M. | Dell'Orto, P. | +17

8

Interpreting Breast International Group (BIG) 1-98 : a randomized, double-blind, phase III trial comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with hormone receptor-positive, early breast cancer

enthalten in: Breast cancer research : BCR | 2011

von Regan, M. | Price, K. | Giobbie-Hurder, A. | +103

9

Differential efficacy of three cycles of CMF followed by tamoxifen in patients with ER-positive and ER-negative tumors : long-term follow up on IBCSG Trial IX

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2011

von Aebi, S. | Sun, Z. | Braun, D. | +14

10

Thresholds for therapies : highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2009

von Goldhirsch, A. | Ingle, J. | Gelber, R. | +47

CommentIn: Ann Oncol. 2010 Feb;21(2):430-1. - PMID 19940009